PARSIPPANY, N.J., Aug. 1, 2011 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that, effective July 5, John L. Parsons Jr. has been named senior vice president and general manager of Interpace BioPharma, LLC, a new wholly-owned subsidiary formed to manage full product commercialization opportunities, such as the two-and-a-half-year agreement for the sales and marketing of a treatment for knee pain announced separately today.
Before joining Interpace BioPharma, Parsons was president and chief commercial officer of the U.S. division of TopoTarget A/S, a Denmark-based biopharmaceutical company focusing on the research and development of oncology products. Prior to that, Parsons was the founder and president from 2000 to 2006 of Parsons Strategic Associates LLC, a healthcare consulting firm offering strategic, operational, technical, investment and partnership services to emerging and established healthcare and pharmaceutical companies. Parsons was previously at Quintiles, Inc. as vice president, emerging markets, after serving as vice president, market planning.
For approximately 25 years, Parsons held a number of increasingly responsible positions with Knoll Pharmaceutical Company, a unit of BASF Pharma, after first joining as a field sales representative. He left Knoll in 1998 as vice president, sales, after earlier holding positions that included vice president, marketing and sales; director of sales; director of marketing; hospital sales manager; regional manager; and product manager.
Parsons holds a BA in Chemistry from Indiana University, Bloomington, Ind., and has completed programs at Wharton School of Business in Strategic Planning, Finance and Leadership.About PDI, Inc. PDI is a leading health care commercialization company providing superior insight-driven, integrated multi-channel message delivery to established and emerging health care companies. The company is dedicated to enhancing engagement with healthcare practitioners and optimizing commercial investments for its clients by providing strategic flexibility, full product commercialization services, innovative multi-channel promotional solutions, and sales and marketing expertise. For more information, please visit the company's website at http://www.pdi-inc.com. SOURCE PDI, Inc.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV